Original Research
Published on 17 Sep 2024
Tonsil explants as a human in vitro model to study vaccine responses
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1425455
- 2,004 views
Type at least 3 characters
2,856 articles
Articles
Original Research
Published on 16 Sep 2024
Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1371156
- 1,691 views
Original Research
Published on 16 Sep 2024
Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1425603
- 1,516 views
Original Research
Published on 13 Sep 2024
Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1445209
- 2,333 views
- 1 citation
Original Research
Published on 12 Sep 2024
Role of circulating T follicular helper subsets following Ty21a immunization and oral challenge with wild type S. Typhi in humans
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1384642
- 1,314 views
Review
Published on 12 Sep 2024
Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1445387
- 2,922 views
Original Research
Published on 12 Sep 2024
Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1461419
- 1,197 views
Review
Published on 11 Sep 2024
Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1392898
- 2,702 views
- 1 citation
Brief Research Report
Published on 09 Sep 2024
Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1469919
- 1,410 views
- 1 citation
Mini Review
Published on 05 Sep 2024
Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1442783
- 3,818 views
- 2 citations
Original Research
Published on 04 Sep 2024
The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1433442
- 3,172 views
Original Research
Published on 03 Sep 2024
Evaluating TRAIL and IP-10 alterations in vaccinated pregnant women after COVID-19 diagnosis and their correlation with neutralizing antibodies
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1415561
- 1,074 views
Original Research
Published on 03 Sep 2024
Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1433075
- 2,259 views
- 1 citation
Clinical Trial
Published on 02 Sep 2024
Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1445459
- 1,876 views
- 2 citations
Systematic Review
Published on 02 Sep 2024
The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1424269
- 2,058 views
- 1 citation
Original Research
Published on 30 Aug 2024
Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1430928
- 1,753 views